Oncoplastic reduction mammaplasty, an effective and safe method of breast conservation - 25/04/18

Abstract |
INTRODUCTION |
Oncoplastic breast conserving surgery (BCS) can enhance both cosmetic and oncologic breast cancer outcomes. This study evaluates the outcomes and complications associated with oncoplastic reduction mammaplasty performed by surgical breast oncologists.
METHODS |
A single institution retrospective chart review of patients undergoing oncoplastic reduction mammaplasty by a surgical breast oncologist for the treatment of breast cancer.
RESULTS |
Seventy-one patients were identified. The average patient age was 59.6 years (range 37–77 years). Average lesion span was 31.4 mm (range 3–166 mm). Six (8.5%) patients required additional surgery to obtain adequate margins. One (1.4%) patient developed recurrent disease during the follow-up interval. No major surgical complications were observed.
CONCLUSION |
Oncoplastic reduction mammaplasty is associated with low rates of re-excision and complications and can be safely and effectively performed by appropriately trained surgical breast oncologists.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Oncoplastic surgery expands the indications for breast conservation. |
• | Oncoplastic surgery can be offered to patients despite presence of comorbidities. |
• | Reduction mammaplasty has excellent cosmetic and oncologic outcomes. |
• | Surgical breast oncologists can effectively perform reduction mammaplasties. |
Plan
Vol 215 - N° 5
P. 910-915 - mai 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?